Introduction
One of the most common causes of musculoskeletal pain is the lateral epicondylitis, which involves common extensor origin of the forearm. Its incidence and prevalence are 1-3% and 10% respectively on general population among working people aged over 45 years old with high-risk jobs (strenuous for the arms). 1, 2 It arises due to repetitive manual work involving overexertion of wrist and finger extensors and imparts significant disability in terms of quality of daily life activities. Clinically, it expresses both direct and indirect tenderness at the lateral epicondyle. 1, 2 Although the diagnosis of lateral epicondylitis is quite straight forward, the optimal management strategy has no consensus. 3 However, non-surgical treatment includes rest, physiotherapy, epicondylar counterforce braces, non-steroidal anti-inflammatory drugs, corticosteroid injection, autologous blood injection, platelet-rich plasma injection, percutaneous radiofrequency thermal treatment, extracorporal shock wave therapy, use of low-level laser therapy, acupuncture and botulinum toxin A injection. 4-7
A systematic review and meta-analysis showed the effect of a range of physical interventions like non-electrotherapeutic interventions such as exercise, manipulation technique, orthotics and taping, acupuncture and electrotherapeutic interventions such as laser, ultrasonic therapy with phonophorosis, electromagnetic field therapy, on various outcomes for lateral epicondylitis and failed to explicate any long term favorable effects over that of a placebo group. 8 Local steroid injection has been proven to provide consistent and predictable shortterm pain relief but no action on reparative process. 9 New treatment options include local injection of platelet-rich plasma, autologous blood, prolotherapy and extracorporeal shock wave therapy. 10-12 Platelet-rich plasma is a concentrate of platelets derived from the patient's own blood. Platelets in platelet-rich plasma contain numerous growth factors and build-up reparative processes.
In lateral epicondylitis, there may be complex changes in the tendon in addition to an inflammatory process. Therefore, platelet-rich plasma owing to its high content of various growth factors may be more efficacious as a healing agent. 13-15 Treatment of patients with chronic lateral epicondylitis with platelet-rich plasma not only reduces pain but also increases function significantly, exceeding the effect of corticosteroid injection even after a follow-up of 2 years. 16 In another study, an injection of platelet-rich plasma improves the pain and function in patients suffering from lateral epicondylitis where conservative management has failed. 17 In another study, the effectiveness of a single injection of platelet-rich plasma, after 3 months, showed that the pain and disability of lateral epicondylitis was not adequately reduced. 18 So, infiltration with autologous blood, buffered platelet-rich plasma or autologous growth factors seem promising, but | Original | Article |
Abstract
Lateral epicondylitis (tennis elbow) is a major cause of musculoskeletal pain involving common extensor origin of the forearm. This study was done to determine the effects of platelet-rich plasma on 15 patients with lateral epicondylitis. Selected patients were given intralesional platelet-rich plasma injection, activity of daily living instructions and paracetamol. Patients were assessed every 14 days interval by visual analogue scale, and the patient rated tennis elbow evaluation. Treatment response according to visual analogue scale and patient rated tennis elbow evaluation tool, the difference of improvement was found in respect to time, from pretreatment W1 (just before 1 st Intervention) score to W11 score in every alternate week (p<0.005). This indicates that intralesional platelet-rich plasma is effective in patients with lateral epicondylitis of elbow. require further investigation. 19 Due to angiogenesis, increase growth factor expression and cell proliferation, platelet-rich plasma therapy is used to increase the reparative process and tensile strength in chronic tendinopathies. 20 Some studies showed that platelet-rich plasma therapy decreases pain and increases functional improvement 16, 17 whereas other studies showed inconclusive results. 18, 15, 21-22 Hence, this study was conducted to find out the efficacy of platelet-rich plasma in terms of pain relief and functional improvement.
Materials and Methods
This prospective experimental study was conducted from March 2017 to February 2018 to determine the effects of platelet-rich plasma on the patients with lateral epicondylitis.
Patients with lateral epicondylitis, age 21 to 60 years and suffering from more than one month, irrespective of sexes were included whereas patients with history of arthritis, trauma, severe anemia, active systemic infection, bleeding disorder were excluded from the study. Fifteen patients were selected for this study. Intralesional platelet-rich plasma injection, activity of daily living instructions and paracetamol were given to each patient. About 3-4 mL of platelet-rich plasma was injected into the lateral epicondylar region and the patient was advised to take paracetamol 500 mg twice daily during the entire treatment period. Regarding activity of daily instruction of patient was advised not to do any twisting activities, weight lifting, sweeping, cloth squeezing, etc.
Patients were assessed every 14 days interval. Intralesional platelet-rich plasma was given in first (W1) and forth (W7) treatment visits. Each visit patients were assessed by visual analogue scale (VAS) and the patient rated tennis elbow evaluation (PRTEE) tools. Statistical analysis was performed by Statistical Packages for Social Sciences (SPSS-21). P value <0.05 was considered as statistically significant.
Blood sample collection and platelet-rich plasma preparation
Selected patients were sent to Transfusion Medicine Department. There about 15-20 mL blood was collected to prepare platelet-rich plasma. Blood was collected in sterile procedure (venepuncture technique almost identical to having a standard blood collection for pathology testing) and allowed it to spin in a centrifuge machine about 3,200 rpm for 15 min. Then, the blood was separated into its various constituents: red blood cells on the bottom, plasma on the top, and platelets in the middle. On the top of the red blood cell layer, there was buffy coat. Then, about 3-4 mL of buffy coat was extracted and which was platelet-rich plasma. This platelet-rich plasma was used in this study. The entire process took less than 30 min.
Results
Baseline characteristic of the patients and analysis of the pain were described in Table I .
Treatment response in relation to weeks according to VAS
There was significant improvement. In respect to time, improvement was started to occur in pretreatment W1 (just before 1 st Intervention) score vs W3 score which was 6.2 ± 2.1 vs 4.0 ± 1.6 respectively (p=0.000). Then, W3 vs W5 score was 4.0 ± 1.6 vs 3.0 ± 1.3 respectively (p=0.001). Then, W5 vs W7 (just before 2 nd Intervention) score 3.0 ± 1.3 vs 2.7 ± 1.0 respectively (p=0.096). Then, W7 (just before 2 nd Intervention) vs W9 score 2.7 ± 1.0 vs 1.4 ± 0.6 respectively ( p=0.000). Then, W9 vs W11 score was 1.4 ± 0.6 vs 0.5 ± 0.5 respectively (p=0.000). This indicates that intralesional platelet-rich plasma was effective in lateral epicondylitis of elbow (Table II) .
Treatment response in relation to weeks according to PRTEE
There was also significant improvement. In respect to time, improvement was started to occur in pretreatment W1 (just before 1 st Intervention) vs W3 score which was 52.2 ± 13.3 vs 42.4 ± 12.9 respectively (p=0.000). Then W3 vs W5 score was 42.4 ± 12.9 vs 34.2 ± 11.5 respectively (p=0.000). Then, W5 vs W7 (just before 2 nd Intervention) score was 34.2 ± 11.5 vs 24.1 ± 7.8 respectively (p=0.000). 
Table I Baseline characteristics of patients and analysis of pain

Analysis of pain Frequency
Character of pain Constant 4
Intermittent 11
Aggravating Factors Heavy weight lifting 3
Twisting movement 1
Repeated stress 11
Relieving factors Rest 14
Taking NSAIDS 1
Data are mean ± SD Then W7 (just before 2 nd Intervention) vs W9 score 24.1 ± 7.8 vs 12.9 ± 5.5 respectively (p=0.000). Then W9 vs W11 score was 12.9 ± 5.5 vs 4.2 ± 3.1 respectively (p=0.000). This indicates that intralesional platelet-rich plasma was effective in lateral epicondylitis of elbow (Table II ).
Discussion
The present study showed that the subjective and objective measures of pain as well as functional parameters were improved following administration of intralesional platelet-rich plasma.
The difference of improvement was found in respect to time, from pretreatment W1 (just before 1st intervention) to W11 score in every alternate week which was statistically significant. Patient's pain was decreased due to subsiding inflammatory process and healing of the diseased tendon by various growth factors secreted from platelets. [13] [14] [15] In a similar study, it was found intralesional platelet-rich plasma showed significant improvement in pain scores using visual analogue scale than placebo at 12 and 24 weeks (p value <0.001). 23 Therefore, platelet-rich plasma was effective as it reduces subjective measures of pain.
In the present study, the difference of improvement was found in respect to time, from pretreatment W1 (just before 1st Intervention) to W11 score in every alternate week. Patient's pain and functional parameters were improved due to subsiding inflammation, tissue regeneration and increase tensile strength. [13] [14] [15] 20 In another study, it was found that intalesional platelet -rich plasma injection showed significant pain relief and gain in function as well as quality of life 6 months after intervention by using patient rated tennis elbow evaluation tool, even with a single platelet-rich plasma injection. Where they showed that the mean baseline to 6-month follow-up scores of the patient rated tennis elbow evaluation questionnaires improved significantly from 54.0 to 63.0. 25 So that the mean platelet-rich plasma was effective as it reduces pain and improves patient's functional improvement.
Hence, treatment response according to visual analogue scale and patient rated tennis elbow evaluation, the difference of improvement was found in respect to time, from pretreatment W1 (just before 1st Intervention) to W11 score in every alternate week, which was supported by other studies. 25-28
Conclusion
Intralesional platelet-rich plasma showed significant improvement in patients with lateral epicondylitis of elbow.
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